Sign in
4

Changes in Ownership

NovoCure Ltd Filed Acc 0001645113-21-000109

Chief Development Officer sold 540 shares at $138.23 ($74,645)

From the SEC's structured data for this filing

Trades in this filing

Leonard Frank X · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-09-02 Sale : show line 1 in the form −540 $138.23 $74,645 87,153 D
Open-market sales · 540 sh · avg $138.23 · $74,645
Loading xslF345X03/wf-form4_163104715467852.xml…